A new report titled “Medical Inhaled Nitric Oxide Market – Forecast to 2032” by Eternal Market, the global medical inhaled nitric oxide industry is projected to grow at a compound annual growth rate (CAGR) of 7.7% from 2023 to 2032, reaching a value of USD 1,490.8 million by the end of the forecast period.
Global medical inhaled nitric oxide industry outlook
In the realm of pharmaceuticals and healthcare, medical inhaled nitric oxide serves as a specialized treatment aimed at addressing respiratory and cardiovascular challenges. This therapeutic gas, comprising nitric oxide, is administered via inhalation to patients in carefully controlled medical settings. Its pivotal role lies in the enhancement of oxygen levels and the reduction of pulmonary hypertension by selectively expanding the blood vessels in the lungs. Medical inhaled nitric oxide finds applications in diverse scenarios, including the management of pulmonary arterial hypertension (PAH), the improvement of oxygenation in neonates suffering from hypoxic respiratory failure, and its role in assisting with adult respiratory distress syndrome (ARDS). Due to the precision required in its administration, this treatment is primarily employed within hospital settings, making a substantial contribution to advanced patient care and overall well-being.
Key Visions
- Estimated CAGR of around 7.7% over the forecast period (2023-2032).
- Global medical inhaled nitric oxide market revenue projected to reach around USD 1,490.8 million, by 2032, from USD 925.7 million in 2022
- Expanding applications in respiratory and cardiovascular disorders are the major market forces.
- By product type, in 2022, nitric oxide delivery systems hold maximum market share.
- By route of administration, in 2022, inhaled nitric oxide gas was the top revenue generator.
- By application, respiratory disorders segment to collect largest revenue in 2023.
- By end user, hospitals segment expected to lead the market in 2023.
- On the basis of region, North America to lead the global market in 2023.
Global medical inhaled nitric oxide industry forces
Growing cases of pulmonary arterial hypertension (PAH) and associated respiratory disorders to drive the market.
The medical inhaled nitric oxide market is witnessing significant growth due to the increasing prevalence of pulmonary arterial hypertension (PAH) and related respiratory disorders. PAH is a debilitating condition characterized by high blood pressure in the pulmonary arteries, leading to strain on the heart and reduced blood flow to the lungs. This condition results in symptoms such as breathlessness, fatigue, and chest pain. PAH can occur without a known cause or can be associated with underlying conditions like connective tissue diseases, congenital heart defects, and liver disease. Recent statistics highlight the urgent need for effective PAH treatments. According to the Pulmonary Hypertension Association, PAH affects approximately 15 to 50 individuals per one million adults worldwide. Moreover, PAH is more prevalent among women and tends to manifest between the ages of 30 and 60. The increased awareness and diagnosis of PAH, along with advancements in medical treatments, have driven the demand for therapies like inhaled nitric oxide, which can specifically dilate pulmonary blood vessels. Consequently, the medical inhaled nitric oxide market is experiencing substantial growth as healthcare providers seek innovative solutions to address the growing burden of PAH and its associated respiratory complications.
Market expansion can be affected by the complexity and cost associated with nitric oxide administration and delivery systems
The medical inhaled nitric oxide market faces a significant drag due to the complexity and associated costs of its administration and delivery systems. Delivering inhaled nitric oxide therapy requires specialized equipment and infrastructure to ensure precise gas delivery to patients in controlled concentrations. This involves the use of intricate delivery systems, including monitors to regulate the nitric oxide dosage. The technical intricacy of these systems necessitates specialized training for healthcare professionals, which adds complexity to their adoption. Furthermore, the expenses related to implementing and maintaining these advanced delivery systems can be substantial. In addition to the equipment costs, ongoing expenditures include maintenance, calibration, and the procurement of the necessary gas supply. Collectively, these factors impose a financial burden on healthcare facilities, potentially limiting the widespread adoption of inhaled nitric oxide therapy. This challenge is particularly relevant in healthcare systems where resource allocation is a critical consideration. According to research published in the “American Journal of Respiratory and Critical Care Medicine,” the cost of providing inhaled nitric oxide therapy for neonates with respiratory failure can be significant, ranging from an estimated $18,000 to $22,000 per patient per day. Moreover, the requirement for skilled personnel and the availability of specialized infrastructure further contribute to operational expenses.
The enduring research and development efforts aimed at improving delivery systems offers growth opportunities
The medical inhaled nitric oxide market is positioned to capitalize on a significant opportunity driven by continuous research and development efforts aimed at improving delivery systems and simplifying the complexities and costs associated with its administration. With a growing demand for precise and efficient therapies, researchers and manufacturers are diligently working to enhance the process of delivering inhaled nitric oxide to patients. These initiatives encompass the creation of user-friendly and effective delivery devices, which could streamline the administration process, reduce training requirements, and potentially alleviate the financial burden on healthcare institutions.
Technological advancements play a central role in unlocking this opportunity, enabling the development of innovative delivery systems that offer improved accuracy and ease of use. By concentrating on refining dosing regimens, treatment durations, and tailoring treatments to individual patient needs, ongoing research contributes to the optimization of inhaled nitric oxide therapy. These advancements hold the potential to transform the landscape of medical treatment, ultimately enhancing patient care and fostering the wider adoption of this valuable therapeutic approach.
The complex regulatory environment and the necessity for strict adherence because of the gas’s classification as a controlled substance could pose challenges to the market’s expansion.
The medical inhaled nitric oxide market encounters a notable obstacle when it comes to navigating the intricate regulatory environment and complying with stringent regulations. This complexity primarily arises from the classification of this gas as a controlled substance due to its potential environmental and health implications. Regulatory bodies frequently impose rigorous guidelines and close oversight on the production, distribution, and utilization of inhaled nitric oxide to ensure its safe and responsible usage. For example, in the U.S., the Food and Drug Administration (FDA) categorizes inhaled nitric oxide as a pharmaceutical and mandates approval for specific medical applications. Additionally, the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) designates nitric oxide as a hazardous substance, emphasizing the importance of cautious handling and proper disposal. These rigorous regulations also apply to international markets, introducing added complexity for manufacturers and healthcare providers operating on a global scale. Complying with these regulations necessitates significant resources and expertise to guarantee that the gas is produced, stored, transported, and administered in a manner that prioritizes patient well-being and minimizes its environmental impact. The evolving nature of regulatory standards and the potential legal consequences for non-compliance present a considerable challenge for participants in the market. Overcoming this challenge necessitates strong collaboration among regulatory authorities, manufacturers, and healthcare institutions to strike a balance between delivering quality patient care and upholding environmental responsibility
Global medical inhaled nitric oxide industry segmentation
Global medical inhaled nitric oxide market segmented by Product Type (Inhaled Nitric Oxide Delivery Systems, Nitric Oxide Sensors and Monitors), By Route of Administration (Inhaled Nitric Oxide Gas, Inhaled Nitric Oxide with Oxygen Mixtures), By Application (Cardiovascular Disorders, Respiratory Disorders), End User (Hospitals, Clinics).
In terms of product type, the current dominant segment in the global market is the nitric oxide delivery systems. These encompass the necessary equipment and mechanisms for the controlled administration of inhaled nitric oxide to patients, ensuring its safe and effective use.
By route of administration, inhaled nitric oxide gas held the largest share in the global market in 2022. Inhaled nitric oxide gas is typically the primary mode of administration in the medical inhaled nitric oxide market as it directly delivers pure nitric oxide for targeted therapeutic effects on pulmonary blood vessels, yielding the desired outcomes.
In terms of application, respiratory disorders constituted the largest share in the global market in 2022. Inhaled nitric oxide gas is generally the preferred choice for addressing respiratory challenges within the medical inhaled nitric oxide market due to its mechanism of improving oxygenation and reducing pulmonary hypertension, aligning well with the treatment of respiratory disorders.
By end-users, hospitals emerged as the largest segment in the global market in 2022. This is attributed to hospitals’ specialized resources and infrastructure, which are essential for the effective administration of this therapy.
Global medical inhaled nitric oxide industry at regional level
North America is set to contribute largest revenue in 2023
North America, particularly the U.S., is a prominent region in the global medical inhaled nitric oxide market. This prominence is a result of the region’s advanced healthcare infrastructure, strong research and development capabilities, and a relatively high incidence of conditions like pulmonary arterial hypertension and respiratory distress syndrome, which necessitate specialized treatments like inhaled nitric oxide therapy. The U.S., with its well-established healthcare system and extensive network of hospitals and medical centers, has been a pioneer in adopting cutting-edge medical technologies, contributing to its leading position in the market.
The medical inhaled nitric oxide market in the U.S. is anticipated to witness a compound annual growth rate (CAGR) of 6.8% from 2022 to 2032.
Scope of the Report
Medical Inhaled Nitric Oxide industry competitors
The global medical inhaled nitric oxide market is commanded by players like:
• Bellerophon Therapeutics
• Praxair Technology, Inc. (Linde plc)
• Mallinckrodt Pharmaceuticals
• GE Healthcare
• Mitsubishi Tanabe Pharma Corporation
• Vero Biotech LLC
• Messer Group
• Air Liquide Healthcare
• Nu-Med Plus
• Beyond Air, Inc.
• Other Players
The global Medical Inhaled Nitric Oxide market is segmented as follows:
By Product Type
• Inhaled Nitric Oxide Delivery Systems
• Nitric Oxide Sensors and Monitors
By Route of Administration
• Inhaled Nitric Oxide Gas
• Inhaled Nitric Oxide with Oxygen Mixtures
By Application
• Cardiovascular Disorders
• Respiratory Disorders
By End User
• Hospitals
• Clinics
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K
o France
o Italy
o Spain
o Rest of Europe (RoE)
• Asia-Pacific (APAC)
o China
o Japan
o India
o Rest of APAC (RoAPAC)
• South America
o Brazil
o Argentina
o Rest of South America
• Middle East & Africa
o GCC
o Israel
o South Africa
o Rest of MEA
*The report scope shall be customized as per the requirements
Chapter 1 Global Medical Inhaled Nitric Oxide Market Overview
1.1 Introduction
1.2 Drivers for Medical Inhaled Nitric Oxide Market
1.3 Restraints for Medical Inhaled Nitric Oxide Market
1.4 Opportunities for Medical Inhaled Nitric Oxide Market
1.5 Trends for Medical Inhaled Nitric Oxide Market
1.6 Macro-economic Factors
1.7 Regulatory Framework
1.8 Opportunity Map Analysis
1.9 Opportunity Orbits
1.10 Market Investment Feasibility Index
1.11 PEST Analysis
1.12 PORTER’S Five Force Analysis
1.13 Go to Market Strategy
1.14 Marketing Strategy
1.15 Technology Roadmap
1.16 Advances in product/services adoption worldwide
1.17 Regional Market Share and BPS Analysis
Chapter 2 Global Medical Inhaled Nitric Oxide Market Competitive Analysis
2.1 Market Competition Scenario Analysis, By Company
2.2 Competitor Landscape
2.3 Major Strategies adopted by key market players (2020-2022)
2.4 Recent Developments/Investments/Announcements
2.5 Company Profiles
2.5.1 Bellerophon Therapeutics
2.5.1.1 Company Overview
2.5.1.2 Business Description
2.5.1.3 Product Portfolio
2.5.1.4 Key Financials
2.5.1.5 Company Presence & Business Segment Analysis – 2022
2.5.1.6 Key Developments
2.5.1.7 SWOT Analysis
2.5.2 Praxair Technology, Inc. (Linde plc)
2.5.2.1 Company Overview
2.5.2.2 Business Description
2.5.2.3 Product Portfolio
2.5.2.4 Key Financials
2.5.2.5 Company Presence & Business Segment Analysis – 2022
2.5.2.6 Key Developments
2.5.2.7 SWOT Analysis
2.5.3 Mallinckrodt Pharmaceuticals
2.5.3.1 Company Overview
2.5.3.2 Business Description
2.5.3.3 Product Portfolio
2.5.3.4 Key Financials
2.5.3.5 Company Presence & Business Segment Analysis – 2022
2.5.3.6 Key Developments
2.5.3.7 SWOT Analysis
2.5.4 GE Healthcare
2.5.4.1 Company Overview
2.5.4.2 Business Description
2.5.4.3 Product Portfolio
2.5.4.4 Key Financials
2.5.4.5 Company Presence & Business Segment Analysis – 2022
2.5.4.6 Key Developments
2.5.4.7 SWOT Analysis
2.5.5 Mitsubishi Tanabe Pharma Corporation
2.5.5.1 Company Overview
2.5.5.2 Business Description
2.5.5.3 Product Portfolio
2.5.5.4 Key Financials
2.5.5.5 Company Presence & Business Segment Analysis – 2022
2.5.5.6 Key Developments
2.5.5.7 SWOT Analysis
2.5.6 Vero Biotech LLC
2.5.6.1 Company Overview
2.5.6.2 Business Description
2.5.6.3 Product Portfolio
2.5.6.4 Key Financials
2.5.6.5 Company Presence & Business Segment Analysis – 2022
2.5.6.6 Key Developments
2.5.6.7 SWOT Analysis
2.5.7 Messer Group
2.5.7.1 Company Overview
2.5.7.2 Business Description
2.5.7.3 Product Portfolio
2.5.7.4 Key Financials
2.5.7.5 Company Presence & Business Segment Analysis – 2022
2.5.7.6 Key Developments
2.5.7.7 SWOT Analysis
2.5.8 Air Liquide Healthcare
2.5.8.1 Company Overview
2.5.8.2 Business Description
2.5.8.3 Product Portfolio
2.5.8.4 Key Financials
2.5.8.5 Company Presence & Business Segment Analysis – 2022
2.5.8.6 Key Developments
2.5.8.7 SWOT Analysis
2.5.9 Nu-Med Plus
2.5.9.1 Company Overview
2.5.9.2 Business Description
2.5.9.3 Product Portfolio
2.5.9.4 Key Financials
2.5.9.5 Company Presence & Business Segment Analysis – 2022
2.5.9.6 Key Developments
2.5.9.7 SWOT Analysis
2.5.10 Beyond Air, Inc.
2.5.10.1 Company Overview
2.5.10.2 Business Description
2.5.10.3 Product Portfolio
2.5.10.4 Key Financials
2.5.10.5 Company Presence & Business Segment Analysis – 2022
2.5.10.6 Key Developments
2.5.10.7 SWOT Analysis
Chapter 3 Global Medical Inhaled Nitric Oxide Market Overview
3.1 Global Medical Inhaled Nitric Oxide Market Outlook (2017-2032)
3.1.1 Global Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) (2017-2023)
3.1.2 Global Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) (2024-2032)
3.2 Global Medical Inhaled Nitric Oxide Market by Region
3.2.1 Global Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
3.2.2 Global Medical Inhaled Nitric Oxide Market Attractiveness Analysis by Region, 2023–2032
3.3 Global Medical Inhaled Nitric Oxide Market by Type
3.3.1 Global Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2032)
3.3.2 Global Medical Inhaled Nitric Oxide Market Attractiveness Analysis by Type, 2023–2032
3.3.3 Global Medical Inhaled Nitric Oxide Market Attractiveness Analysis by Region, 2023–2032
3.4 Global Medical Inhaled Nitric Oxide Market by Route of Administration
3.4.1 Global Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2017-2032)
3.4.2 Global Medical Inhaled Nitric Oxide Market Attractiveness Analysis by Route of Administration, 2023–2032
3.5 Global Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) by Region
3.5.1 Global Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
3.5.2 Global Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
3.6 Global Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) by Type
3.6.1 Global Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2023)
3.6.2 Global Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Type (2024-2032)
3.7 Global Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) by Route of Administration
3.7.1 Global Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2017-2023)
3.7.2 Global Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2024-2032)
3.8 Global Medical Inhaled Nitric Oxide Market Y-o-Y Growth Rate Comparison 2018–2032
3.8.1 Global Medical Inhaled Nitric Oxide Market Y-o-Y Growth Rate by Region
3.8.2 Global Medical Inhaled Nitric Oxide Market Y-o-Y Growth Rate by Type
3.8.3 Global Medical Inhaled Nitric Oxide Market Y-o-Y Growth Rate by Route of Administration
3.9 Global Medical Inhaled Nitric Oxide Market Share Comparison 2017–2032
3.9.1 Global Medical Inhaled Nitric Oxide Market Share by Region
3.9.2 Global Medical Inhaled Nitric Oxide Market Share by Type
3.9.3 Global Medical Inhaled Nitric Oxide Market Share by Route of Administration
Chapter 4 North America Medical Inhaled Nitric Oxide Market Overview
4.1 North America Market Snapshot
4.1.1 Regional Overview
4.1.1.1 US
4.1.1.2 Canada
4.1.1.3 Mexico
4.2 North America Medical Inhaled Nitric Oxide Market Outlook (2017-2032)
4.2.1 North America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) (2017-2023)
4.2.2 North America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) (2024-2032)
4.3 North America Medical Inhaled Nitric Oxide Market by Region
4.3.1 North America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
4.3.2 North America Medical Inhaled Nitric Oxide Market Attractiveness Analysis by Region, 2023–2032
4.4 North America Medical Inhaled Nitric Oxide Market by Type
4.4.1 North America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2032)
4.4.2 North America Medical Inhaled Nitric Oxide Market Attractiveness Analysis by Type, 2023–2032
4.4.3 North America Medical Inhaled Nitric Oxide Market Attractiveness Analysis by Region, 2023–2032
4.5 North America Medical Inhaled Nitric Oxide Market by Route of Administration
4.5.1 North America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2017-2032)
4.5.2 North America Medical Inhaled Nitric Oxide Market Attractiveness Analysis by Route of Administration, 2023–2032
4.6 North America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) by Region
4.6.1 North America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
4.6.2 North America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
4.7 North America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) by Type
4.7.1 North America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2023)
4.7.2 North America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Type (2024-2032)
4.8 North America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) by Route of Administration
4.8.1 North America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2017-2023)
4.8.2 North America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2024-2032)
4.9 North America Medical Inhaled Nitric Oxide Market Y-o-Y Growth Rate Comparison 2018–2032
4.9.1 North America Medical Inhaled Nitric Oxide Market Y-o-Y Growth Rate by Region
4.9.2 North America Medical Inhaled Nitric Oxide Market Y-o-Y Growth Rate by Type
4.9.3 North America Medical Inhaled Nitric Oxide Market Y-o-Y Growth Rate by Route of Administration
4.1 North America Medical Inhaled Nitric Oxide Market Share Comparison 2017–2032
4.10.1 North America Medical Inhaled Nitric Oxide Market Share by Region
4.10.2 North America Medical Inhaled Nitric Oxide Market Share by Type
4.10.3 North America Medical Inhaled Nitric Oxide Market Share by Route of Administration
Chapter 5 Europe Medical Inhaled Nitric Oxide Market Overview
5.1 Europe Market Snapshot
5.1.1 Regional Overview
5.1.1.1 Germany
5.1.1.2 United Kingdom
5.1.1.3 France
5.1.1.4 Italy
5.1.1.5 Spain
5.1.1.6 Russia
5.1.1.7 Rest of Europe
5.2 Europe Medical Inhaled Nitric Oxide Market Outlook (2017-2032)
5.2.1 Europe Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) (2017-2023)
5.2.2 Europe Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) (2024-2032)
5.3 Europe Medical Inhaled Nitric Oxide Market by Region
5.3.1 Europe Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
5.3.2 Europe Medical Inhaled Nitric Oxide Market Attractiveness Analysis by Region, 2023–2032
5.4 Europe Medical Inhaled Nitric Oxide Market by Type
5.4.1 Europe Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2032)
5.4.2 Europe Medical Inhaled Nitric Oxide Market Attractiveness Analysis by Type, 2023–2032
5.4.3 Europe Medical Inhaled Nitric Oxide Market Attractiveness Analysis by Region, 2023–2032
5.5 Europe Medical Inhaled Nitric Oxide Market by Route of Administration
5.5.1 Europe Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2017-2032)
5.5.2 Europe Medical Inhaled Nitric Oxide Market Attractiveness Analysis by Route of Administration, 2023–2032
5.6 Europe Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) by Region
5.6.1 Europe Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
5.6.2 Europe Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
5.7 Europe Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) by Type
5.7.1 Europe Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2023)
5.7.2 Europe Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Type (2024-2032)
5.8 Europe Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) by Route of Administration
5.8.1 Europe Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2017-2023)
5.8.2 Europe Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2024-2032)
5.9 Europe Medical Inhaled Nitric Oxide Market Y-o-Y Growth Rate Comparison 2018–2032
5.9.1 Europe Medical Inhaled Nitric Oxide Market Y-o-Y Growth Rate by Region
5.9.2 Europe Medical Inhaled Nitric Oxide Market Y-o-Y Growth Rate by Type
5.9.3 Europe Medical Inhaled Nitric Oxide Market Y-o-Y Growth Rate by Route of Administration
5.1 Europe Medical Inhaled Nitric Oxide Market Share Comparison 2017–2032
5.10.1 Europe Medical Inhaled Nitric Oxide Market Share by Region
5.10.2 Europe Medical Inhaled Nitric Oxide Market Share by Type
5.10.3 Europe Medical Inhaled Nitric Oxide Market Share by Route of Administration
Chapter 6 Asia Pacific Medical Inhaled Nitric Oxide Market Overview
6.1 Asia Pacific Market Snapshot
6.1.1 Regional Overview
6.1.1.1 China
6.1.1.2 India
6.1.1.3 Japan
6.1.1.4 Australia
6.1.1.5 Rest of Asia Pacific
6.2 Asia Pacific Medical Inhaled Nitric Oxide Market Outlook (2017-2032)
6.2.1 Asia Pacific Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) (2017-2023)
6.2.2 Asia Pacific Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) (2024-2032)
6.3 Asia Pacific Medical Inhaled Nitric Oxide Market by Region
6.3.1 Asia Pacific Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
6.3.2 Asia Pacific Medical Inhaled Nitric Oxide Market Attractiveness Analysis by Region, 2023–2032
6.4 Asia Pacific Medical Inhaled Nitric Oxide Market by Type
6.4.1 Asia Pacific Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2032)
6.4.2 Asia Pacific Medical Inhaled Nitric Oxide Market Attractiveness Analysis by Type, 2023–2032
6.4.3 Asia Pacific Medical Inhaled Nitric Oxide Market Attractiveness Analysis by Region, 2023–2032
6.5 Asia Pacific Medical Inhaled Nitric Oxide Market by Route of Administration
6.5.1 Asia Pacific Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2017-2032)
6.5.2 Asia Pacific Medical Inhaled Nitric Oxide Market Attractiveness Analysis by Route of Administration, 2023–2032
6.6 Asia Pacific Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) by Region
6.6.1 Asia Pacific Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
6.6.2 Asia Pacific Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
6.7 Asia Pacific Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) by Type
6.7.1 Asia Pacific Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2023)
6.7.2 Asia Pacific Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Type (2024-2032)
6.8 Asia Pacific Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) by Route of Administration
6.8.1 Asia Pacific Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2017-2023)
6.8.2 Asia Pacific Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2024-2032)
6.9 Asia Pacific Medical Inhaled Nitric Oxide Market Y-o-Y Growth Rate Comparison 2018–2032
6.9.1 Asia Pacific Medical Inhaled Nitric Oxide Market Y-o-Y Growth Rate by Region
6.9.2 Asia Pacific Medical Inhaled Nitric Oxide Market Y-o-Y Growth Rate by Type
6.9.3 Asia Pacific Medical Inhaled Nitric Oxide Market Y-o-Y Growth Rate by Route of Administration
6.1 Asia Pacific Medical Inhaled Nitric Oxide Market Share Comparison 2017–2032
6.10.1 Asia Pacific Medical Inhaled Nitric Oxide Market Share by Region
6.10.2 Asia Pacific Medical Inhaled Nitric Oxide Market Share by Type
6.10.3 Asia Pacific Medical Inhaled Nitric Oxide Market Share by Route of Administration
Chapter 7 South America Medical Inhaled Nitric Oxide Market Overview
7.1 South America Market Snapshot
7.1.1 Regional Overview
7.1.1.1 Brazil
7.1.1.2 Argentina
7.1.1.3 Rest of South America
7.2 South America Medical Inhaled Nitric Oxide Market Outlook (2017-2032)
7.2.1 South America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) (2017-2023)
7.2.2 South America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) (2024-2032)
7.3 South America Medical Inhaled Nitric Oxide Market by Region
7.3.1 South America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
7.3.2 South America Medical Inhaled Nitric Oxide Market Attractiveness Analysis by Region, 2023–2032
7.4 South America Medical Inhaled Nitric Oxide Market by Type
7.4.1 South America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2032)
7.4.2 South America Medical Inhaled Nitric Oxide Market Attractiveness Analysis by Type, 2023–2032
7.4.3 South America Medical Inhaled Nitric Oxide Market Attractiveness Analysis by Region, 2023–2032
7.5 South America Medical Inhaled Nitric Oxide Market by Route of Administration
7.5.1 South America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2017-2032)
7.5.2 South America Medical Inhaled Nitric Oxide Market Attractiveness Analysis by Route of Administration, 2023–2032
7.6 South America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) by Region
7.6.1 South America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
7.6.2 South America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
7.7 South America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) by Type
7.7.1 South America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2023)
7.7.2 South America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Type (2024-2032)
7.8 South America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) by Route of Administration
7.8.1 South America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2017-2023)
7.8.2 South America Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2024-2032)
7.9 South America Medical Inhaled Nitric Oxide Market Y-o-Y Growth Rate Comparison 2018–2032
7.9.1 South America Medical Inhaled Nitric Oxide Market Y-o-Y Growth Rate by Region
7.9.2 South America Medical Inhaled Nitric Oxide Market Y-o-Y Growth Rate by Type
7.9.3 South America Medical Inhaled Nitric Oxide Market Y-o-Y Growth Rate by Route of Administration
7.1 South America Medical Inhaled Nitric Oxide Market Share Comparison 2017–2032
7.10.1 South America Medical Inhaled Nitric Oxide Market Share by Region
7.10.2 South America Medical Inhaled Nitric Oxide Market Share by Type
7.10.3 South America Medical Inhaled Nitric Oxide Market Share by Route of Administration
Chapter 8 Middle East and Africa Medical Inhaled Nitric Oxide Market Overview
8.1 Middle East and Africa Market Snapshot
8.1.1 Regional Overview
8.1.1.1 GCC
8.1.1.2 South Africa
8.1.1.3 Israel
8.1.1.4 Rest of Middle East and Africa
8.2 Middle East and Africa Medical Inhaled Nitric Oxide Market Outlook (2017-2032)
8.2.1 Middle East and Africa Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) (2017-2023)
8.2.2 Middle East and Africa Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) (2024-2032)
8.3 Middle East and Africa Medical Inhaled Nitric Oxide Market by Region
8.3.1 Middle East and Africa Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
8.3.2 Middle East and Africa Medical Inhaled Nitric Oxide Market Attractiveness Analysis by Region, 2023–2032
8.4 Middle East and Africa Medical Inhaled Nitric Oxide Market by Type
8.4.1 Middle East and Africa Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2032)
8.4.2 Middle East and Africa Medical Inhaled Nitric Oxide Market Attractiveness Analysis by Type, 2023–2032
8.4.3 Middle East and Africa Medical Inhaled Nitric Oxide Market Attractiveness Analysis by Region, 2023–2032
8.5 Middle East and Africa Medical Inhaled Nitric Oxide Market by Route of Administration
8.5.1 Middle East and Africa Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2017-2032)
8.5.2 Middle East and Africa Medical Inhaled Nitric Oxide Market Attractiveness Analysis by Route of Administration, 2023–2032
8.6 Middle East and Africa Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) by Region
8.6.1 Middle East and Africa Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
8.6.2 Middle East and Africa Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
8.7 Middle East and Africa Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) by Type
8.7.1 Middle East and Africa Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2023)
8.7.2 Middle East and Africa Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Type (2024-2032)
8.8 Middle East and Africa Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) by Route of Administration
8.8.1 Middle East and Africa Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2017-2023)
8.8.2 Middle East and Africa Medical Inhaled Nitric Oxide Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2024-2032)
8.9 Middle East and Africa Medical Inhaled Nitric Oxide Market Y-o-Y Growth Rate Comparison 2018–2032
8.9.1 Middle East and Africa Medical Inhaled Nitric Oxide Market Y-o-Y Growth Rate by Region
8.9.2 Middle East and Africa Medical Inhaled Nitric Oxide Market Y-o-Y Growth Rate by Type
8.9.3 Middle East and Africa Medical Inhaled Nitric Oxide Market Y-o-Y Growth Rate by Route of Administration
8.1 Middle East and Africa Medical Inhaled Nitric Oxide Market Share Comparison 2017–2032
8.10.1 Middle East and Africa Medical Inhaled Nitric Oxide Market Share by Region
8.10.2 Middle East and Africa Medical Inhaled Nitric Oxide Market Share by Type
8.10.3 Middle East and Africa Medical Inhaled Nitric Oxide Market Share by Route of Administration
Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources
